Valvular heart disease cardiac catheterization: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{CMG}} ==2006 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease - Indications for Cardiac Catheterization in Aortic Stenosis Patients...") |
m (Bot: Removing from Primary care) |
||
(10 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} | {{CMG}} | ||
{{Valvular heart disease}} | |||
==2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary<ref name="pmid24589852">{{cite journal| author=Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA et al.| title=2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. | journal=Circulation | year= 2014 | volume= | issue= | pages= | pmid=24589852 | doi=10.1161/CIR.0000000000000029 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24589852 }} </ref>== | |||
{|class="wikitable" | |||
|- | |||
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' [[Cardiac catheterization]] for hemodynamic assessment is recommended in symptomatic patients when noninvasive tests are inconclusive or when there is a discrepancy between the findings on noninvasive testing and physical examination regarding severity of the valve lesion. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | |||
|} | |||
==2006 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease - Indications for Cardiac Catheterization in Aortic Stenosis Patients (DO NOT EDIT) <ref name="pmid16880336">{{cite journal |author=Bonow RO, Carabello BA, Kanu C, ''et al.'' |title=ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons |journal=Circulation |volume=114 |issue=5 |pages=e84–231 |year=2006|month=August |pmid=16880336 |doi=10.1161/CIRCULATIONAHA.106.176857 |url=}}</ref>== | ==2006 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease - Indications for Cardiac Catheterization in Aortic Stenosis Patients (DO NOT EDIT) <ref name="pmid16880336">{{cite journal |author=Bonow RO, Carabello BA, Kanu C, ''et al.'' |title=ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons |journal=Circulation |volume=114 |issue=5 |pages=e84–231 |year=2006|month=August |pmid=16880336 |doi=10.1161/CIRCULATIONAHA.106.176857 |url=}}</ref>== | ||
{|class="wikitable" | |||
|- | |||
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Coronary angiography is recommended before [[Aortic valve replacement]] in patients with [[aortic stenosis]] at risk for [[Coronary heart disease]]. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]]) <nowiki>"</nowiki> | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''2.''' [[Cardiac catheterization]] for hemodynamic measurements is recommended for assessment of severity of [[Aortic stenosis|AS]] in symptomatic patients when noninvasive tests are inconclusive or when there is a discrepancy between noninvasive tests and clinical findings regarding severity of AS. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])<nowiki>"</nowiki> | |||
|- | |||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''3.''' Coronary angiography is recommended before [[AVR]] in patients with [[Aortic stenosis]] for whom a pulmonary autograft (Ross procedure) is contemplated and if the origin of the coronary arteries was not identified by noninvasive technique. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])<nowiki>"</nowiki> | |||
|} | |||
{|class="wikitable" | |||
|- | |||
|colspan="1" style="text-align:center; background:LightCoral"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] (Harm) | |||
|- | |||
|bgcolor="LightCoral"|<nowiki>"</nowiki>'''1.''' [[Cardiac catheterization]] for hemodynamic measurements is not recommended for the assessment of severity of [[AS]] before [[AVR]] when noninvasive tests are adequate and concordant with clinical findings. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' <nowiki>"</nowiki> | |||
|- | |||
|bgcolor="LightCoral"| <nowiki>"</nowiki>'''2.''' Cardiac catheterization for hemodynamic measurements is not recommended for the assessment of [[Left Ventricle#Function|LV function]] and severity of [[AS]] in asymptomatic patients. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' <nowiki>"</nowiki> | |||
|} | |||
==References== | ==References== | ||
{{Reflist|2}} | |||
{{WH}} | |||
{{WS}} | |||
[[Category:Cardiology]] | |||
[[Category:Valvular heart disease]] |
Latest revision as of 00:38, 30 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Valvular heart disease Microchapters |
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary[1]
Class I |
"1. Cardiac catheterization for hemodynamic assessment is recommended in symptomatic patients when noninvasive tests are inconclusive or when there is a discrepancy between the findings on noninvasive testing and physical examination regarding severity of the valve lesion. (Level of Evidence: C)" |
2006 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease - Indications for Cardiac Catheterization in Aortic Stenosis Patients (DO NOT EDIT) [2]
Class I |
"1. Coronary angiography is recommended before Aortic valve replacement in patients with aortic stenosis at risk for Coronary heart disease. (Level of Evidence: B) " |
"2. Cardiac catheterization for hemodynamic measurements is recommended for assessment of severity of AS in symptomatic patients when noninvasive tests are inconclusive or when there is a discrepancy between noninvasive tests and clinical findings regarding severity of AS. (Level of Evidence: C)" |
"3. Coronary angiography is recommended before AVR in patients with Aortic stenosis for whom a pulmonary autograft (Ross procedure) is contemplated and if the origin of the coronary arteries was not identified by noninvasive technique. (Level of Evidence: C)" |
Class III (Harm) |
"1. Cardiac catheterization for hemodynamic measurements is not recommended for the assessment of severity of AS before AVR when noninvasive tests are adequate and concordant with clinical findings. (Level of Evidence: C) " |
"2. Cardiac catheterization for hemodynamic measurements is not recommended for the assessment of LV function and severity of AS in asymptomatic patients. (Level of Evidence: C) " |
References
- ↑ Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0000000000000029. PMID 24589852.
- ↑ Bonow RO, Carabello BA, Kanu C; et al. (2006). "ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons". Circulation. 114 (5): e84–231. doi:10.1161/CIRCULATIONAHA.106.176857. PMID 16880336. Unknown parameter
|month=
ignored (help)